On a crisp, clear Sunday morning in early June, a Mount Sinai Health System team of more than 100 strong participated in the 2015 Liver Life Walk at Hudson River Park. Among the enthusiastic participants who walked the three-mile course and raised more than $20,000 to support the American Liver Foundation was Jennifer Long, a patient at Mount Sinai’s Recanati/Miller Transplantation Institute. (more…)
Sean P. Pinney, MD, was recently named the first Director of Heart Failure and Transplantation for the Mount Sinai Health System. He will also continue to serve as Director of Advanced Heart Failure and Transplantation at The Mount Sinai Hospital and Associate Professor of Medicine (Cardiology) at Icahn School of Medicine at Mount Sinai, where he has led a number of clinical trials in heart failure, cardiac transplantation, and mechanical circulatory support. (more…)
The Mount Sinai Transplant Living Center, which provides convenient and affordable overnight accommodations to patients and their families receiving care at the Recanati/Miller Transplantation Institute (RMTI), has undergone a full renovation, featuring new kitchens, bathrooms, and furniture.
The renovation was a generous gift from benefactors Ken and Meryl Sherman who were looking to give back to RMTI on the fourteenth anniversary of Mrs. Sherman’s successful kidney transplant, for which Mr. Sherman was the donor. (more…)
As a college sophomore, Joanna Adler was unexpectedly diagnosed with a rare illness called Wilson’s disease, and underwent an urgent liver transplant at The Mount Sinai Hospital. Today, 16 years later, Ms. Adler remains close to her physician, Leona Kim-Schluger, MD, the Sidney J. Zweig Professor of Medicine at Icahn School of Medicine at Mount Sinai and Associate Director of the Recanati/Miller Transplantation Institute. Ms. Adler is also a strong supporter of Mount Sinai, which she credits for saving her life.
Drug-induced liver injury (DILI) is the single most common reason for regulatory actions concerning drugs, including failure to gain approval for marketing, removal from the market place and restriction of prescribing indications.
DILI is also a significant cause of morbidity and mortality in many patient populations. Due to its idiosyncratic nature, variable presentation and the vast number of potential causative drugs as well as herbal and dietary supplements, DILI is often diagnosed late in its course when patients have severe liver disease. DILI, including acute liver failure requiring liver transplantation, can happen anytime to anyone taking medications, even over the counter medications. Unfortunately, there are no tests to predict who is at risk nor to diagnose this problem. (more…)